NatureNeurosciencePeer-reviewed journal article
TDP-43 represses cryptic exon inclusion in FTD/ALS gene UNC13A
X. Rosa MaiD, Mercedes PrudencioiD, Yuka Mitsuhashi KoikeiD, Sarat C. VatsavayaiiD, Garam KımiD, Fred Harbinski, Adam BrineriD, Caitlin M. RodrigueziD, Caiwei GuoiD, Tetsuya AkiyamaiD, Hermann Broder SchmidtiD, Beryl B. CummingsiD, David W. WyattiD, Katherine KuryloiD, Georgiana MilleriD, Shila Mekhoubad, Nathan A Sallee, Gemechu Mekonnen, Laura R. GanseriD, Jack D. RubieniD, Karen R. Jansen‐WestiD, Casey N. CookiD, Sarah R. PicklesiD, Björn OskarssoniD, Neill R. Graff‐RadfordiD, , Aaron D. GitleriD
Abstract
A hallmark pathological feature of neurodegenerative diseases amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) is the depletion of RNA-binding protein TDP-43 from the nucleus of neurons in the brain and spinal cord. A major function of TDP-43 is as a repressor of cryptic exon inclusion during RNA splicing. Single nucleotide polymorphisms (SNPs) in UNC13A are among the strongest genome-wide association study (GWAS) hits associated with FTD/ALS in humans, but how those variants increase risk for disease is unknown. Here we show that TDP-43 represses a cryptic exon splicing event in UNC13A. Loss of TDP-43 from the nucleus in human brain, neuronal cell lines, and iPSC-derived motor neurons resulted in the inclusion of a cryptic exon in UNC13A mRNA and reduced UNC13A protein expression. Remarkably, the top variants associated with FTD/ALS risk in humans are located in the cryptic exon harboring intron itself and we show that they increase UNC13A cryptic exon splicing in the face of TDP-43 dysfunction. Together, our data provide a direct functional link between one of the strongest genetic risk factors for FTD/ALS (UNC13A genetic variants) and loss of TDP-43 function.
- organism: human
- assay: bulk RNA-seq
- research focus: differential expression
- research focus: gene regulatory network inference
- approach: statistical model
- Citations
- 574
- FWCI
- 57.65
- Field percentile
- top 1%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Common ALS/FTD risk variants in UNC13A exacerbate its cryptic splicing and loss upon TDP-43 mislocalization
Anna‐Leigh Brown, Oscar G. Wilkins, … Pietro Fratta·bioRxiv·Apr 2, 2021
- TDP-43 pathology triggers SRRM4-dependent cryptic splicing of G3BP1 in ALS/FTD
Hana Fakim, Asmita Ghosh, … Christine Vande Velde·bioRxiv·Sep 17, 2025
- Cryptic splicing in synaptic and membrane excitability genes links TDP-43 loss to neuronal dysfunction
Caiwei Guo, Kuchuan Chen, … Aaron D. Gitler·Science Translational MedicinePeer-reviewed·Jun 3, 2026
- TDP-43 dysfunction induces cryptic circular RNAs in ALS/FTD
Dario Dattilo, Flaminia Pellegrini, … Pietro Fratta·bioRxiv·Sep 20, 2026
- Restoring multiple TDP-43 cryptic targets, but not solely Unc13a, rescues motor neuron disease
Aswathy Peethambaran Mallika, Meghraj Singh Baghel, … Philip C. Wong·bioRxiv·Sep 18, 2026
- Loss of TDP-43 induces synaptic dysfunction that is rescued by UNC13A splice-switching ASOs
Matthew J. Keuss, Peter Harley, … Pietro Fratta·bioRxiv·Jun 20, 2024